Horien Biochemical Technology Co., Ltd. (7814) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Horien Biochemical Technology Co., Ltd. (7814:TWSE), powered by AI.

Current Price
$35.40
Sector
Healthcare
What is the Horien Biochemical Technology Co., Ltd. stock price forecast?

Horien Biochemical Technology Co., Ltd. is currently trading at $35.40. View real-time AI analysis on Alpha Lenz.

What is Horien Biochemical Technology Co., Ltd. insider trading activity?

View the latest insider trading data for Horien Biochemical Technology Co., Ltd. on Alpha Lenz.

What is Horien Biochemical Technology Co., Ltd.'s P/E ratio?

View Horien Biochemical Technology Co., Ltd.'s valuation metrics on Alpha Lenz.

Horien Biochemical Technology Co., Ltd.

TWSE · 7814
NT$35.40+0.10(+0.28%)
Ask about Horien Biochemical Technology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Horien Biochemical Technology Co., Ltd.'s ROE is -1.7%. Explore profitability and growth together.

Ask for details

Company Overview

Horien Biochemical Technology Co., Ltd. is a leading manufacturer in the health care equipment sector, specializing in the development and production of collagen-based medical devices and cosmetic raw materials. Founded in 2006 and headquartered in Taichung, Taiwan, the company focuses on innovative solutions for regenerative medicine, dental surgery, medical beauty, ophthalmology, and general surgical applications. Its product portfolio encompasses dental wound protection materials, collagen dental matrices, collagen regeneration films, bone fillers, bioink, and artificial bone substitutes, serving both medical and cosmetic industries. Horien’s advanced R&D centers feature state-of-the-art laboratories and clean rooms, delivering high-quality, safe, and effective products that are exported to markets including Europe, the USA, and China. The firm’s commitment to research and collaboration with international experts underscores its significant role in advancing medical technology and regenerative healthcare solutions in Taiwan and globally.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$83.04MRevenue
0.00Shares Out
0Employees

Margins

70.51%Gross
4.48%EBITDA
-9.82%Operating
-6.03%Pre-Tax
-6.03%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

14.64%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.54%ROA
-1.69%ROE
-1.53%ROIC

Financial Health

NT$64.58MCash & Cash Equivalents
NT$-38.43MNet Debt
8.89%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Horien Biochemical Technology Co., Ltd. (ticker: 7814) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 35.4 with a P/E ratio of -x and P/B of -x.

ROE is -1.69% and operating margin is -9.82%. Annual revenue is $83M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Horien Biochemical Technology Co., Ltd. (7814) Stock Forecast 2026 $35.40 — Price, Financials & Analyst Targets | Alpha Lenz